---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-024927"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-08-20T23:59:59+00:00"
generated_at: "2026-05-17T11:18:52.432576+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical granted USPTO patent expanding LIBERTY system TAM to 6M+ US procedures

## Summary
- Patent covers modular robotic system with interchangeable tool-receiver units attachable to base.
- IP portfolio now: 12 patents granted globally, 57 patent applications pending.
- Enables future adaptation for wider endovascular procedures; US TAM could grow from 2.5M to 6M+ annual procedures.
- Company continues commercial readiness plans for LIBERTY system while awaiting FDA 510(k) clearance.
- CEO Harel Gadot: near-term focus remains on peripheral market and commercial readiness.

## SEC filing metadata
- accession: 0001641172-25-024927
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-08-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000164117225024927/0001641172-25-024927-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000164117225024927/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-024927
- JSON: https://secwatch.observer/filing/0001641172-25-024927.json
- Plain text: https://secwatch.observer/filing/0001641172-25-024927.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.